prescription drugs – Clomiphene QB http://clomipheneqb.com/ Sat, 19 Mar 2022 19:42:16 +0000 en-US hourly 1 https://wordpress.org/?v=5.9 https://clomipheneqb.com/wp-content/uploads/2021/10/cropped-icon-32x32.png prescription drugs – Clomiphene QB http://clomipheneqb.com/ 32 32 COVID-19: Pharmacies urge people not to stockpile as prescription drugs run out https://clomipheneqb.com/covid-19-pharmacies-urge-people-not-to-stockpile-as-prescription-drugs-run-out/ Thu, 17 Mar 2022 05:44:46 +0000 https://clomipheneqb.com/covid-19-pharmacies-urge-people-not-to-stockpile-as-prescription-drugs-run-out/

COVID-19 has hit medical supply chains hard in New Zealand and overseas. Since early March, illness among New Zealand staff at medical warehouses and freight providers has aggravated the situation.

A diabetes drug that was supposed to arrive in New Zealand three months ago has just arrived.

“It has become a real problem in recent weeks in terms of drug shortages, drug changes, confusion with patients about what drugs they are taking, and it has caused a lot of extra work for GPs and doctors. pharmacists,” he added. Dr Bryan Betty, Medical Director of the Royal NZ College of GPs, says.

Pharmac says it’s doing its best.

“New Zealand has actually held up very well thanks to existing contracts between Pharmac and its suppliers to hold three months of stock in-country at all times,” said Lisa Williams, operations manager at Pharmac.

“We really appreciate that people have been affected, what we’re asking is not to stockpile medicine at home – we need to make sure there’s enough for everyone. You may need to be waiting.”

Dr Betty says shortages of some drugs mean GPs have to prescribe alternatives, which is making some patients nervous.

“It’s extra stress for the patients,” says Dr. Betty.

And pharmacists see this first hand too.

“There are safe alternatives to most medications, but if someone is normally prescribed 50mg, we might have to go down to 12.5mg and tell them to take four pills a day, and that’s where let the confusion begin for people,” says pharmacist Burgess.

Pharmac insists local supply chain issues will improve by next month as staff return from isolation.

But expect to see further long delays for some specialized baby formulas, nutritional supplements and prescription drugs due overseas.

[ad_2]Source link

]]>
Woman claims Brookside police stole $5,000 and prescription pills during traffic stop https://clomipheneqb.com/woman-claims-brookside-police-stole-5000-and-prescription-pills-during-traffic-stop/ Wed, 16 Mar 2022 03:55:00 +0000 https://clomipheneqb.com/woman-claims-brookside-police-stole-5000-and-prescription-pills-during-traffic-stop/

BROOKSIDE, Ala. (WBRC) – The town of Brookside is facing another lawsuit. A woman accuses the police of stealing her prescription drugs and thousands of dollars.

Last month, at a town hall meeting on the Brookside police controversy, Jeanetta Jones described her encounter with Brookside police. She says that when they arrested her last year, she complied with their orders.

“Then he asked me how can you afford to drive a car like this? I said because God blessed me with it,” Jones said.

Jones was then told to get out of the car. The police searched him with a K-9. After that was over, Jones got back in her car and noticed that she was missing prescription drugs and money.

“They took $5,000 and 120 Percocets from me,” Jones said.

Jones laid all that out in a lawsuit filed this week against Brookside, former police chief Mike Jones and two unnamed officers. Jones says he was prescribed the pills for the pain and the money was used to pay bills and his mortgage.

“My back is torn from the ground up. I got injured in 2010,” Jones said.

“They didn’t give him a receipt. They didn’t arrest her for that. They just took it,” said Roger Appell, Jones’ attorney. “When they left with her money and her prescription drugs, she asked them why are you doing this to us? Why are you doing this to me? And they looked at it and said because we can.

Jones and Appell want Brookside to be held accountable.

“It seemed like nothing more than a shakedown,” Jones said of the traffic stop.

“She had to come back with more money to pay her mortgage payments. The pain and suffering she endured. The angst, but on top of that we want to punish the City of Brookside and the officers who did this so it doesn’t happen again,” Appell said.

Jones was never charged with anything. The lawsuit says Brookside also violated his civil rights. She is asking for monetary damages.

We are still awaiting a response from Brookside, but in previous lawsuits they have told us that they do not comment on ongoing litigation.

CLICK HERE TO GET THE WBRC FOX6 NEWS APP

Subscribe to our WBRC newsletter and get the latest local news and weather delivered straight to your email.

Copyright 2022 WBRC. All rights reserved.

[ad_2]Source link

]]>
Rep. Dylan Roberts: A leader in saving insulin and prescription drugs https://clomipheneqb.com/rep-dylan-roberts-a-leader-in-saving-insulin-and-prescription-drugs/ Tue, 15 Mar 2022 17:30:32 +0000 https://clomipheneqb.com/rep-dylan-roberts-a-leader-in-saving-insulin-and-prescription-drugs/

Colorado has led the way in reducing the cost of life-saving prescription drugs. We faced it against special interests that tried to stop us, and we did it in a bipartisan way, because people’s health and financial security are more important than politics. Now is the time for the nation to follow our example.

In 2019, I drafted the nation’s first bill that capped the cost of insulin copays at $100 per month. I enlisted bipartisan sponsors in the Colorado House and Senate, where it passed both houses and was then signed into law by the Governor – making history not just in Colorado, but across the country. country.

In 2021, I returned to the Capitol with a follow-up bill to ensure the uninsured or underinsured can access the insulin they need to survive at an affordable $50 per month. Again, this bill passed the legislature with bipartisan support and was signed into law by the governor.



We passed these historic laws not because of politics, but because they save money and lives. Insulin is really the poster child for soaring prescription drug prices in the country, and this increase is hurting people’s health and bank accounts – for no good reason.

A vial of insulin cost around $21 in 1996. In 2019, that same vial of insulin (without changing the chemical composition) cost over $300. Since most type 1 diabetics and many type 2 diabetics require several vials of insulin per month, people were paying between $600 and $2,000 per month for a drug they needed to survive, even though the cost of insulin production remained unchanged from the 1990s.



For diabetics, insulin is like oxygen – without it, you die. So, Coloradians and Americans have been held hostage to price increases without any recourse.

Because of these excessive prices, more than 40% of diabetics in Colorado tragically admitted to rationing their insulin in 2020. Fortunately, Coloradons no longer need to pay exorbitant prices just to survive because our legislators – regardless the party – got together and passed my insulin bills. Additionally, we laid the foundation for similar price controls for other life-saving prescription drugs by adopting the Prescription Drug Affordability Board in 2021. Now is the time for our model of saving money and lives to go national.

Fortunately, national leaders are taking notice. Members of Congress from both parties began advocating for an insulin price cap this year and President Biden even said in the 2022 State of the Union address, “Let’s cap the cost insulin at $35 a month.

One in 10 Americans has diabetes. There are too many Americans experiencing the difficulties that come with living with diabetes. With 78% of Americans supporting proposals to make insulin more affordable, there is clearly an appetite and an acute need for insulin pricing reform.

Fortunately, nearly 20 states have begun tackling this issue independent of political parties, many with Republican legislatures and governors. Given the popularity and bipartisan appeal of this issue, its ability to save money and lives, and the example we’ve set in Colorado, there’s no consistent reason why not every state in the country – as well as the federal government – ​​can follow our example.

We even set an example for lawmakers in Washington, DC to aspire to. Don’t take it from me, take it from Sen. John Kennedy, R-La., who prioritizes making insulin more affordable for his constituents. He says of this goal: “Hundreds of thousands of Louisianans depend on life-saving medications like insulin…and 12% of adults in our state have diabetes…Our people need access to affordable medications.

On a similar note across the aisle, Senators Raphael Warnock, D-Ga., and ours, Michael Bennet, D-Colo., are sponsoring a bill to cap the price of insulin . Respectfully, I encourage Republicans and Democrats in Washington, D.C. to follow our lead in putting aside political differences and working together to create legislation that makes insulin and other prescription drugs accessible to Americans. .

Will there be relentless opposition from big pharma throughout this endeavor? Absoutely. Will business leaders, pharmacy benefit managers and insurance companies stop at nothing to preserve the status quo? You bet. But I ask anyone considering tackling this issue: If Colorado can be a game-changer when it comes to insulin and drug pricing reform, why can’t you? We just showed the whole country that it can be done.

If you would like to know if you or someone you know qualifies for the Insulin Affordability Program, please visit DOI.Colorado.gov/for-consumers/consumer-resources/insulin-affordability-program.

As always, please contact me about this topic or any other at 970-846-3054 or dylan.roberts.house@state.co.us.

Dylan Roberts, Colorado Rep.
Courtesy picture

Representative Dylan Roberts serves Routt County and Eagle County in the Colorado State House.

[ad_2]Source link

]]>
OptimizeRx acquires EvinceMed, a specialty drug prescribing initiation platform https://clomipheneqb.com/optimizerx-acquires-evincemed-a-specialty-drug-prescribing-initiation-platform/ Tue, 15 Mar 2022 12:00:12 +0000 https://clomipheneqb.com/optimizerx-acquires-evincemed-a-specialty-drug-prescribing-initiation-platform/

Enter Wall Street with StreetInsider Premium. Claim your one week free trial here.


ROCHESTER, Mich., March 15, 2022 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions that help patients start and stay on treatment, today announced a definitive agreement to acquire the EvinceMed platform and associated assets. EvinceMed is a leader in providing end-to-end automation for specialty pharmaceutical transactions. Acquisition includes comprehensive market access management platform that helps pharmaceutical manufacturers, platform providers and pharmacies improve patient access, speed of treatment and program activation financial accessibility.

Through the EvinceMed platform, OptimizeRx will be able to help patients access the medications they need by simplifying the process of prescribing specialty products, automating manual steps to determine drug eligibility and affordability, and introducing electronic registration and medical documentation into the OptimizeRx workflow. network of over 300 electronic health record (EHR) systems, e-prescribing platforms and account-based marketing technologies spanning over 700,000 providers. The integration of the EvinceMed and OptimizeRx platforms has already begun with an exclusive collaboration that started last year. The full integration of technology assets will strengthen the Company’s ability to help patients initiate and maintain treatment.

While specialty drugs represent only 2.2% of total prescription volume in the United States, they accounted for more than 45% of total pharmaceutical spending, or $218.6 billion in 20191,2. The cost and increasing use of specialty medications has exposed unique barriers to the prescribing process and patient access. Manufacturer support programs provide essential services for access, affordability and adherence to prescription drugs. However, a recent survey of 10,000 patients across multiple therapy areas found that only 20% of patients were aware of these programs3. Physicians and their staff can help patients enroll in these programs, but the enrollment process is often time-consuming and physicians remain dissatisfied with the patient support options currently available. In addition, less than 10% of patient registrations for these support programs are currently done electronically4.

“We are delighted that EvinceMed has grown from an exclusive technology partner over the past year to being part of the team. Given the success we have seen working together, this combination strengthens our position to serve our customers. across the entire HCP network and throughout the patient journey – from the moment the physician logs into their EHR to the point of dispensing at the pharmacy,” said William Febbo, CEO of OptimizeRx. “This acquisition provides significant high-margin cross-selling opportunities to our growing customer base of leading life sciences companies, while further strengthening our business through vertical integration and helping to build momentum to our key performance indicators We expect this acquisition to benefit revenue growth in 2023 as we further grow our network around connectivity with additional partners. »

David Jackson, CEO of EvinceMed, said, “We are very excited to join the OptimizeRx team. The impact of our combined technologies and the reach and scale that OptimizeRx has with pharmaceutical manufacturers is a game-changer for patient access to specialty medicines. By automating the processes and tasks that need to be done before specialty medications are filled and dispensed, we can get patients on treatment much faster and at a lower overall cost. »

OptimizeRx Chief Commercial Officer Steve Silvestro added, “Our commitment to leveraging technology to help providers and patients access the tools they need to improve outcomes is a mission-driven effort. EvinceMed’s assets give us additional resources to do this while expanding the reach of the network to distribution points, a goal we have been pursuing for a long time. Prescribing assistance through automation for providers will both speed up workflows and remove barriers to the specialty prescribing process, ensuring patients have timely access to innovative therapies that change their lives that they need.

OptimizeRx is committed to investing in innovation to bring more workflow-integrated digital solutions to meet the commercialization goals of life science organizations. OptimizeRx currently provides solutions to 19 of the top 20 pharmaceutical manufacturers and seeks to continue to generate long-term, sustainable returns for its customers while supporting initiatives that improve health outcomes. A recent market study commissioned by OptimizeRx revealed that supporting access to specialty medications was a market worth over $12 billion. This acquisition further diversifies OptimizeRx’s revenue streams as the company scales to meet customer needs in this space.

Sources:

  1. US Drug Use and Spending, 2018 Review and Outlook to 2023, IKIVIA Institute, 2019
  2. Spending on specialty drugs is skyrocketing. Can managing the form bring it back to earth?, Managed Care, 2019
  3. Patient services: Pharma’s best kept secret. Accenture Life Sciences, 2016.
  4. Specialty Pharmacy Automation: Identifying Gaps, NCPDP, 2015. https://pocp.com/wp-content/uploads/PDF/6-%20NCPDP_2015_ED_Summit_SpecialtyRx.pdf

About OptimizeRxOptimizeRx is a best-in-class health technology company enabling care-driven engagement between life science organizations, healthcare providers, and patients at critical times throughout the patient care journey. patients. Connecting more than 60% of US healthcare providers and millions of their patients through the smartest technology platform integrated into a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications.

For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com.

Important Cautions Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “expects”, “has intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify such forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the growth, business plans and future performance of the Company. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those stated, contemplated or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other risks summarized in the company’s annual report on Form 10-K for l fiscal year ended December 31, 2020, its subsequent quarterly reports on Form 10-Q and its other filings with the Securities and Exchange Commission.

Contact OptimiserRx

Andy D’Silva, Senior Vice President of Corporate Finance[email protected]

Contact person for media relations Maira Alejandra, Media Relations Manager [email protected]

Investor RelationsAshley RobinsonLifeSci Advisors, LLC[email protected]

main logo

Source: OptimizeRx Corporation

[ad_2]Source link

]]>
Senses. Capito, Shaheen, Reps. McKinley, Thompson introduce bipartisan Digital Prescription Therapy Access Act https://clomipheneqb.com/senses-capito-shaheen-reps-mckinley-thompson-introduce-bipartisan-digital-prescription-therapy-access-act/ Fri, 11 Mar 2022 11:30:58 +0000 https://clomipheneqb.com/senses-capito-shaheen-reps-mckinley-thompson-introduce-bipartisan-digital-prescription-therapy-access-act/

WASHINGTON, (DC) – Today, U.S. Senators Shelley Moore Capito (RW.Va.) and Jeanne Shaheen (DN.H.), along with U.S. Representatives David McKinley (RW.Va.-01) and Mike Thompson (D-Calif.-05), introduced bipartisan legislation to increase access to Prescription Digital Therapeutics (PDT).

The legislation, known as the Digital Prescription Therapy Access Act of 2022, would expand Medicare coverage to include PDTs, which are software-based disease treatments designed to directly treat disease, including safety and effectiveness have been tested in randomized, US-evaluated clinical trials. Food and Drug Administration (FDA), and prescribed by health care providers. PDTs are designed and tested much like traditional prescription drugs, but rather than swallowing a pill or getting an injection, patients receive cognitive therapy through software.

“Prescription Digital Therapeutics is a great example of how innovative technology can address some of the healthcare challenges that providers and patients continue to face,” said Senator Capito. “The Digital Prescription Therapy Access Act would enable more patients living with a wide variety of diseases and conditions – from substance and opioid use disorders and mental and behavioral health to diabetes and Parkinson’s disease – to more effectively access the care and support they need. and deserve.

“We must harness the power of innovation in medicine to improve access and treatment options for patients. That’s why I’m helping introduce bipartisan, bicameral legislation to expand access to cognitive therapies that have been proven to treat a range of illnesses, including substance use disorders and mental health,” said Senator Shaheen. “Our bill ensures that these digital prescription therapies are covered by Medicare so that more patients, including the elderly, have access to the cutting-edge care they deserve.”

“West Virginia has the highest overdose death rate in the nation and we know all too well the losses families affected by this crisis have endured. It’s critical that we do more to address mental health and addiction and seek new approaches that can improve people’s lives,” Congressman McKinley said. “This legislation will ensure that innovative and effective treatments, like Prescription Digital Therapeutics, are more widely available to help combat this scourge.”

“Living in the modern era requires medicine to adapt to meet the needs and challenges of access to quality care. Digital prescription therapies, software-based health treatments, have significant benefits for patients and provide a new tool to help improve people’s lives,” said Congressman Thompson. “PDTs have been shown to benefit people with mental health conditions like depression and addiction, providing an alternative to traditional medicine. I am proud to introduce this bipartisan bill alongside Senators Shaheen and Capito and Congressman McKinley to ensure seniors on Medicare have access to these innovative treatments.

“Digital therapy is revolutionizing healthcare, addressing many unmet medical needs and, most importantly, improving the health of many Americans,” said Andy Molnar, CEO of the Digital Therapeutics Alliance. “The introduction of this legislation to establish new categories of Medicare and Medicaid benefits for digital prescription therapies is a critical step in ensuring that these evidence-based treatments reach those who need them most. We are grateful. of the work of the sponsors of the bill and we look forward to working with a broad coalition of patients, providers and others to get this into law.

“Providing patient-centred health care means supporting people ‘where they are’. We stand with the sponsors of the bill and for all those who will benefit from increased access to digital prescription therapies. We can’t think of a more convenient and effective healing modality than people literally having access to support at their fingertips,” said Dr. Dawn Nickel, Founder of the SHE RECOVERS Foundation.

The legislation is supported by national patient advocacy organizations such as the Kennedy Forum, Shatterproof, SHE RECOVERS Foundation and Young People in Recovery, as well as the Digital Therapeutics Alliance.

West Virginia Daily News has served Greenbrier and Monroe counties since 1852.

[ad_2]Source link

]]>
Amid rising medical debt, push for solutions to prescription drug costs https://clomipheneqb.com/amid-rising-medical-debt-push-for-solutions-to-prescription-drug-costs/ Fri, 11 Mar 2022 05:07:55 +0000 https://clomipheneqb.com/amid-rising-medical-debt-push-for-solutions-to-prescription-drug-costs/

Welcome to Thomas Insights – every day we post the latest news and analysis to keep our readers up to date with what’s happening in the industry. Sign up here to get the day’s top stories straight to your inbox.

The topic of health care took center stage in President Joe Biden’s State of the Union address on March 1, 2022. Along with the president calling on Medicare to set higher standards for nursing homes ensuring seniors receive optimal care, Biden urged Congress to pass legislation that would allow Medicare to negotiate lower prices for prescription drugs and said insulin should be capped at $35 per month “to everyone can afford it.” Medicare is currently prohibited by federal law from directly negotiating drug prices with manufacturers.

According to a report, America pays 2.56 times more for prescription drugs than the rest of the world. “One in ten Americans has diabetes,” Biden said in his speech, noting that drug companies charge people “up to 30 times more” than the $10 it costs to make a vial of insulin. Biden added that with the suggested price cut, “pharmaceutical companies will still do very well” while the 200,000 young Americans with type 1 diabetes can receive the life-saving drugs they need without going into debt. .

Americans have more medical debt than previously known

Medical debt is the largest form of debt owed by Americans, and recent studies show they owe roughly twice as much as previously known, with collection agencies holding $140 billion worth of medical bills in 2020. unpaid; a huge jump from an estimated $81 billion in medical debt just four years earlier in 2016. These debts are especially larger in areas not participating in the Affordable Care Act’s Medicaid expansion program.

“The US bailout is helping millions of families on Affordable Care Act plans save $2,400 a year on their health care premiums,” Biden continued. “Let’s close the coverage gap and make these savings permanent.

Many are in favor of Biden’s proposal. In a recent poll, 61% of Americans agreed that cutting health care costs is the second most important priority the President and Congress need to address — second only to fixing the economy. Others, however, should resist.

Pharmaceutical lobbying organization PhRMA, in response to Biden’s speech, responded with a statement urging the president to find a “holistic” solution. It should “address abusive practices within the insurance system” while protecting the creation of new treatments and cures. The statement adds: “Allowing the government to set the price of drugs is not the solution. We know this story will end with less access to medicines and less future innovation, and we know there is a better way.

Image Credit: Arne Beruldsen/Shutterstock.com

3D printing could take aviation to new heightsNext story »

More industry trends

[ad_2]Source link

]]>
Senators Shaheen, Capito, Reps. McKinley, and Thompson introduce the bipartisan Digital Prescription Therapy Access Act https://clomipheneqb.com/senators-shaheen-capito-reps-mckinley-and-thompson-introduce-the-bipartisan-digital-prescription-therapy-access-act/ Thu, 10 Mar 2022 19:12:27 +0000 https://clomipheneqb.com/senators-shaheen-capito-reps-mckinley-and-thompson-introduce-the-bipartisan-digital-prescription-therapy-access-act/

March 10, 2022

(Washington, DC) – U.S. Senators Jeanne Shaheen (D-NH) and Shelley Moore Capito (R-WV) and U.S. Representatives David McKinley (WV-01) and Mike Thompson (CA-05) introduced bipartisan legislation to increase access to Digital Therapeutic Prescribing (PDT).

The legislation, known as Access to Digital Prescription Therapy Act of 2022, would expand Medicare coverage to include PDTs, which are software-based disease treatments designed to directly treat disease, whose safety and effectiveness have been tested in randomized clinical trials, reviewed by the Food and United States Drug Administration (FDA) and prescribed by health care providers. PDTs are designed and tested much like traditional prescription drugs, but rather than swallowing a pill or getting an injection, patients receive cognitive therapy through software.

“We must harness the power of innovation in medicine to improve access and treatment options for patients. That’s why I’m helping introduce bipartisan, bicameral legislation to expand access to cognitive therapies proven to treat a range of illnesses, including substance use disorders and health conditions. mental”, said Senator Shaheen. “Our bill ensures these digital prescription therapies are covered by Medicare so that more patients, including the elderly, have access to the cutting-edge care they deserve.”

“Prescription Digital Therapeutics is a great example of how innovative technology can address some of the healthcare challenges that providers and patients continue to face,” said Senator Capito. “The Digital Prescription Therapy Access Act would enable more patients living with a wide variety of diseases and conditions – from substance and opioid use disorders and mental and behavioral health to diabetes and Parkinson’s disease – to more effectively access the care and support they need. and deserve.

“West Virginia has the highest overdose death rate in the country and we know all too well the losses families affected by this crisis have endured. It is essential that we do more to address mental health and addictions and seek new approaches that can improve people’s lives,” said Congressman McKinley. “This legislation will ensure that innovative and effective treatments, like Prescription Digital Therapeutics, are more widely available to help combat this scourge.”

“Living in the modern era requires medicine to adapt to meet the needs and challenges of access to quality care. Digital prescription therapies, software-based health treatments, have significant benefits for patients and provide a new tool to help improve people’s lives,” said Congressman Thompson. “PDTs have been shown to benefit people with mental health conditions like depression and addiction, providing an alternative to traditional medicine. I am proud to introduce this bipartisan bill alongside Senators Shaheen and Capito and Congressman McKinley to ensure seniors on Medicare have access to these innovative treatments.

For the full text of the invoice, click on here.

Throughout the pandemic, Shaheen has been a leader in strengthening and expanding access to telehealth in New Hampshire and across the country. Shaheen helps lead bipartisan legislation, the Rural Telehealth Access Protection Act, which would make various current Medicare telehealth flexibilities permanent, including flexibilities to provide audio-only forms of telehealth services. This would ensure that Medicare patients can continue to have access to the services and consultations they need and that patients in rural areas without broadband access will still be able to use audio-only and phone visits with their doctors. In April 2020, Shaheen, Manchin and Moran led a bipartisan group of senators to urge the US Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) to increase telehealth by phone or audio uniquely. reimbursements equivalent to other audiovisual telehealth reimbursements. The following month, CMS answered Shaheen’s call and updated guidelines to align Medicare reimbursement for telephone health services with Medicare reimbursement for video telehealth. Shaheen also helped introduce the bipartisan Create Opportunity Now for Necessary and Effective Care Technologies (CONNECT) for Health Law, which would expand coverage of telehealth services through Medicare, make COVID-19 telehealth flexibilities permanent, improve health outcomes, and make it easier for patients to safely connect with their doctors. Last April, Shaheen also introduced legislation providing for Medicare reimbursement for audio and video telehealth services provided by home health agencies during the COVID-19 public health crisis and future public health emergencies.

###



Previous post

[ad_2]Source link

]]>
Amazon Pharmacy launches prescription discount card for Blue Plan members in 5 states https://clomipheneqb.com/amazon-pharmacy-launches-prescription-discount-card-for-blue-plan-members-in-5-states/ Wed, 09 Mar 2022 23:06:00 +0000 https://clomipheneqb.com/amazon-pharmacy-launches-prescription-discount-card-for-blue-plan-members-in-5-states/

Amazon’s pharmacy arm has launched a new prescription savings card that aims to make it easier for insured customers to save on drugs. The card, called MedsYourWay, is now available to Plan Bleu members in five states.

Today, insured people who want to save money on a prescription are often faced with a difficult choice: use their health plan and pay only the co-payment. or access a potentially cheaper service cash price through a discount card or savings program. Although the cash option sometimes costs less upfront, the money spent is generally not applied to a plan’s deductible or maximum payout.

“OOften discount cards act as an alternative rather than an addition to your current benefits package,” explained Dr. Nworah Ayogu, Chief Medical Officer of Amazon Pharmacy, in an interview at the ViVE conference in Miami Beach.

But that’s not the case with the Amazon Pharmacy discount card, which is administered by InsideRx and offered by Prime Therapeutics and its Blue Cross and Blue Shield plan customers. Including Horizon Blue Cross Blue Shield from New Jersey, Blue Cross Blue Shield from Nebraska, Blue Cross Blue Shield from Alabama, Florida Blue and Blue Cross and Blue Shield from Kansas.

“With MedsYourWay, all of those payments will now apply to their maximum spend and deductibles,” Ayogu said.

However, it cannot be used in any pharmacy. Use MedsYourWaycustomers must obtain their medications from Amazon Pharmacy.

As an alternative, the Amazon Prime Rx benefit offers savings and discounts on prescriptions at over 60,000 pharmacies, including Amazon Pharmacy. But, at present, this is offered directly to consumers and not through insurance plans. Thus, money spent on lower cost drugs does not necessarily count towards a health plan deductible or maximum payout, as with other cards and discount programs.

By providing convenient access to prescriptions, reducing costs and increasing price transparency, and providing 24/7 access to a pharmacist over the phone for customers, Amazon Pharmacy strives to enable patients to easier to get the drugs they need, Ayogu said.

Eligible Blue Plan members who select Amazon like their pharmacy will have a streamlined enrollment experience and real-time, plan-specific pricing on prescription drugs, according to the company. Amazon Pharmacy also offers free home delivery and free two-day delivery for Amazon First members.

Data shows that 20-30% of prescriptions are never filled, which can have serious health consequences. In the United States, a lack of medication adherence is estimated to cause approximately 125,000 deaths and at least 10% of hospitalizations, and cost the US healthcare system between $100 billion and $289 billion annually, according to a research review published in the Annals of Internal Medicine.

However, correcting the problem is not as simple as asking patients to fill their prescriptions.

There are so many barriers to joining,” Ayogu said.

Amazon Pharmacy seeks to lower the cost of drugs and make it easier to access prescription drugs, among other efforts to help break down those barriers, he said. The company also hopes to expand its MedsYourWay program and offer it through other insurance plans in the future.

We look forward to partnering with any plans that want to move forward with customer-focused innovations,” said Ayogu.

Photo credit; hillwoman2. Getty Images

[ad_2]Source link

]]>
Claiming prescription drug costs have risen nearly twice as much as income depends primarily on cash https://clomipheneqb.com/claiming-prescription-drug-costs-have-risen-nearly-twice-as-much-as-income-depends-primarily-on-cash/ Tue, 08 Mar 2022 18:03:58 +0000 https://clomipheneqb.com/claiming-prescription-drug-costs-have-risen-nearly-twice-as-much-as-income-depends-primarily-on-cash/

The cost of prescription drugs in the United States has long been a hot topic for voters.

On July 9, 2021, Joe Biden signed an executive order to enact “aggressive legislative reforms” that would lower prescription drug prices. He promised to do so during the election campaign.

In Wisconsin, State Treasurer Sarah Godlewski, a Democratic candidate for the US Senate, addressed a similar theme. She hopes to face U.S. Senator Ron Johnson, a Republican, in November 2022.

“The skyrocketing cost of prescription drugs is plaguing Wisconsin residents and hurting Americans in every corner of the country. As drug companies reap record profits, people are skipping pills to make their prescriptions last a little longer, while others must choose between their groceries and their lifesaving drugs,” Godlewski said in a Feb. 18, 2022 campaign statement “Here in Wisconsin, prescription drug costs have risen at nearly twice the rate higher than Wisconsinite’s average income from 2015 to 2019.”

The last part of Godlewski’s claim caught our attention.

Have prescription drug costs increased at almost twice the rate of the average Wisconsinan’s income?

We’ll take a look.

Resident income

When asked to back up Godlewski’s claim, his campaign team quoted an AARP article headline “Prescription drug costs are rising almost twice as fast as incomes of Wisconsin residents” . AARP is a nonprofit, nonpartisan organization active on issues that affect people 50 and older.

The average annual cost of prescription drug therapy increased 26.3% between 2015 and 2019, while the annual income of Wisconsin residents increased only 13.9%,” AARP reported.

But an audit of the US Census Bureau’s American Community Survey shows the median income of Wisconsin residents rose 15.2%, from $55,638 in 2015 to $64,168 in 2019.

Why the gap?

The 13.9% increase applies to residents over the age of 50, while the 15.3% increase applies to all residents.

So, Godlewski was generally on target, but went a little over the mark in his phrasing.

Learn more about drug costs

In Wisconsin, according to the 2020 “Governor’s Task Force on Prescription Drug Price Reduction,” prescription drugs are estimated to have cost residents more than $1.3 billion in total in 2019.

Meanwhile, an AARP chart – “Impact of High Rx Prices to Wisconsin Residents” – looked at the price increase of three specific drugs between 2015 and 2020:

  • Revlimid, a cancer treatment, went from $185,574 to $267,583, up 44%

  • Victoza, a diabetes treatment, went from $7,936 to $11,300, up 42%

  • Spiriva inhaler, used for asthma and COPD, rose from $3,886 to $5,289, up 36%

The report went on to say that the retail prices of 76% of the most widely used brand name prescription drugs (198 of 260) increased in price in 2020 – and 92% of those price increases (183 of 198) were higher than the general inflation rate in 2002, which was 1.3%.

Separately, a February 25, 2022 report from the Kaiser Family Foundation, a nonprofit focused on national health issues, found that prices had risen faster than inflation for half of all covered drugs. by Medicare in 2020.

Our decision

Godlewski said that “in Wisconsin, prescription drug costs increased at a rate nearly twice the average Wisconsinite income from 2015 to 2019.”

The average annual cost of prescription drug treatment increased by 26.3% over this period. The increase in income for all Wisconsin residents was actually 15.2%. The figure cited by Godlewski is for people aged 50 and over, whose income increased by 13.9%.

For an exact statement but requiring clarification or additional information, our rating is generally true.

[ad_2]Source link

]]>
Paris Jackson pleads for prescription drug after Michael’s death https://clomipheneqb.com/paris-jackson-pleads-for-prescription-drug-after-michaels-death/ Sat, 05 Mar 2022 09:53:12 +0000 https://clomipheneqb.com/paris-jackson-pleads-for-prescription-drug-after-michaels-death/ Paris Jackson has made an impassioned plea for doctors to stop “handing out addictive drugs like candy”, likening it to “selling a gun”.

Paris Jackson urged psychiatrists to invest in a “better vetting process” before “handing out addictive drugs like candy.”

“There should be a better verification process [in everything]: before you take drugs — or anything even more dangerous, like selling a gun — you should check them,” Jackson told LVR magazine.

“It’s important in all kinds of situations. It can be as simple as a job, or as complicated as a medicine or a weapon. Psychiatrists dispense addictive drugs like candy without really controlling the patient. There is no harm in checking.

The 23-year-old’s father, Michael Jackson, died in 2009 of cardiac arrest following a lethal combination of prescription drugs. Since her father’s death, Paris has struggled with drug and alcohol addiction, suicide attempts and self-harm.

“[I attempted suicide] several times. It wasn’t until it became public,” Jackson told Rolling Stone in 2017, referring to her high-profile incident in June 2013, in which she took 20 Motrin pills and broke down. split wrists. Jackson later revealed that this was her “third strike”, so she subsequently sought residential treatment.

Jackson received treatment at a behavior modification school in Utah during her sophomore and freshman years of high school, but she confessed that in addition to solving some problems, it also created new ones.

“There’s a lot at stake in these schools,” she explained in her new interview with LVR magazine. “They may close and reopen under a different name to avoid lawsuits, and it depends on how state laws work.”

“If a child decides to call their parents and say, ‘Please get me out of here’, this center will probably hang up the phone and call the parents back and say, ‘Don’t listen to them. , they’re manipulating you, doing everything they can to get out of here. Who are you going to listen to, a troubled teenager or a medical professional?”

In 2017, Jackson said she had previously been prescribed the same antidepressants as her father, but was not currently taking any medication.

This article originally appeared in the New York Post and is reproduced here with permission.

[ad_2]Source link

]]>